Omega-3 supplement for childhood apraxia of speech
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests an omega-3 supplement (called Omega-DEK) to see if it helps improve speech in children with childhood apraxia of speech, a motor speech disorder. It is a randomized trial, meaning some children will get the supplement and others will get a placebo (a dummy), and neither you nor the researchers will know which one your child receives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a confirmed diagnosis of childhood apraxia of speech (CAS) by a speech therapist.
- For the main study, children must be between 3 and 6 years old. A separate expanded group allows children 2 and older.
- Your child must be able to take a daily supplement (a liquid or chewable) and speak/understand English.
- Your child cannot have certain health issues, like seizures, heart rhythm problems, a known bleeding disorder, or a history of brain injury or genetic conditions like Down syndrome.
- Your child must not have taken fish oil, vitamin E, or other supplements (like probiotics) in the last 3 months.
- Your child cannot start new chronic medications or special diets during the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a motor-based speech therapy program for children with childhood apraxia of speech (CAS), a motor speech disorder that makes it hard to plan and coordinate the movements needed for speech. The study may help improve your child's speaking skills.
This trial tests whether a specific supplement can help adults with Level 1 autism. It is open only to Italian-speaking participants aged 18–35 who do not have other major mental health or brain conditions.
This trial tests a speech therapy program for children with rare genetic conditions who also have childhood apraxia of speech, a disorder where the brain has trouble planning the movements needed for speech. The therapy is intensive—three sessions a week for four weeks—and may help improve your child's ability to speak clearly.
This trial tests a new speech therapy method that uses ultrasound to show children a live picture of their tongue movements on a screen. It aims to help children with childhood apraxia of speech improve their speech by giving them visual feedback as they practice sounds.
This Phase 2 study tests whether esomeprazole helps children with autism. It looks at children who are generally healthy, take stable medicines, and can reliably attend visits so their care team can track changes during the study.
This trial tests whether omega-3 supplements can help children and teens with autism spectrum disorder (ASD). It aims to see if taking omega-3 improves core symptoms like social communication and behavior.
Hear when a new Childhood Apraxia of Speech trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.